Julien Olivet, MS, PhD

Cited by

	All	Since 2019
Citations	107	107
h-index	4	4
i10-index	2	2

2020202120222023202410 16 29 35 17

Public access

View all

10 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Sibusiso MasekoUniversity of Liege,GIGA-Signal Transduction UnitVerified email at uliege.be
mike calderwoodLead Scientist, Dana-Farber Cancer InstituteVerified email at dfci.harvard.edu
Marc VidalProfessor of Genetics, Harvard Medical SchoolVerified email at dfci.harvard.edu
David E HillDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
Johan Van WeyenberghKU Leuven - Department of Microbiology, Immunology and Transplantation - Rega Institute for MedicalVerified email at kuleuven.be
Christoph GorgullaHarvard UniversityVerified email at g.harvard.edu
Tina O'GradyVerified email at tulane.edu
Keisuke KataokaDivision of Hematology, Department of Medicine, Keio University School of MedicineVerified email at umin.ac.jp
Kourosh Salehi-AshtianiNew York University Abu DhabiVerified email at nyu.edu
Mr Olivier HermineProfessor of hematology,Verified email at aphp.fr
Thandokuhle NtombelaUniversity of KwaZulu-NatalVerified email at stu.ukzn.ac.za
Haribabu ArthanariHarvard Medical SchoolVerified email at hms.harvard.edu
Kalyan DasProfessor, Rega Institute, KU Leuven, BelgiumVerified email at kuleuven.be
Han RemautVrije Universiteit Brussel / VIBVerified email at vub.be
Kerstin Spirohn-FitzgeraldDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
Christopher SeckerZuse Institute Berlin & Max Delbrueck Center for Molecular MedicineVerified email at zib.de
Luc WillemsUniversity of LiegeVerified email at ulg.ac.be
Dae-Kyum KimRoswell Park Comprehensive Cancer CenterVerified email at roswellpark.org
Deeya SahaTAGC INSERMVerified email at inserm.fr
Javier De Las RivasCancer Research Center (IBMCC, CSIC/USAL & IBSAL), Salamanca, SpainVerified email at usal.es

Julien Olivet, MS, PhD

Postdoctoral Researcher at Rega Institute, KU Leuven

Verified email at mailfence.com

Chemical Biology Protein-protein interactions Chromatin remodelers HDAC Cryo-EM


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Maximizing binary interactome mapping with a minimal number of assays SG Choi, J Olivet, P Cassonnet, PO Vidalain, K Luck, L Lambourne, ... Nature communications 10 (1), 3907, 2019	58	2019
The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape C Vandermeulen, T O’grady, J Wayet, B Galvan, S Maseko, M Cherkaoui, ... PLoS pathogens 17 (9), e1009919, 2021	25	2021
Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells D Kerselidou, BS Dohai, DR Nelson, S Daakour, N De Cock, ... Science advances 7 (19), eabe8349, 2021	9	2021
A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals J Olivet, SB Maseko, AN Volkov, K Salehi-Ashtiani, K Das, ... Molecular Therapy 30 (5), 1797-1800, 2022	6	2022
AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor P Trepte, C Secker, J Olivet, J Blavier, S Kostova, SB Maseko, I Minia, ... Molecular Systems Biology 20 (4), 428-457, 2024	2	2024
Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction SB Maseko, Y Brammerloo, I Van Molle, A Sogues, C Martin, C Gorgulla, ... Antiviral research 217, 105675, 2023	2	2023
A quantitative mapping approach to identify direct interactions within complexomes P Trepte, C Secker, SG Choi, J Olivet, ES Ramos, P Cassonnet, S Golusik, ... bioRxiv, 2021.08. 25.457734, 2021	2	2021
Expanding the HDAC druggable landscape beyond enzymatic activity J Olivet, SG Choi, S Sierra, TM O'Grady, M de la Fuente Revenga, F Laval, ... bioRxiv, 2023	1	2023
Interactome and structural basis for targeting the human T-cell leukemia virus Tax oncoprotein SB Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, ... bioRxiv, 2021.08. 25.457680, 2021	1	2021
The viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape C Vandermeulen, T O’Grady, B Galvan, M Cherkaoui, A Desbuleux, ... bioRxiv, 2021.01. 18.427104, 2021	1	2021
AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor (preprint) P Trepte, C Secker, S Kostova, SB Maseko, SG Choi, J Blavier, I Minia, ...		2023
Selective disruption of histone deacetylase complexes by small-molecule inhibitors of protein interactions J OLIVET University of Liège, Belgium, 2021		2021
Structural basis for targeting the human T-cell leukemia virus Tax oncoprotein and syntenin-1 interaction using a small molecule S Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, ...		2021
Exostosin-1 Glycosyltransferase Regulates Endoplasmic Reticulum Architecture and Dynamics D Kerselidou, BS Dohai, DR Nelson, S Daakour, N De Cock, DK Kim, ... bioRxiv, 2020.09. 02.275925, 2020		2020
Systematic assessment of druggable cavities in a histone deacetylase complex J Olivet Keystone Symposium, Phenotypic Drug Discovery: Recent Advances and Insights …, 2019		2019
Design and optimization of assays to detect protein-protein interactions J Olivet Master internship Report, Harvard Medical School & Dana-Farber Cancer …, 2015		2015
Synthesis of an alginate/SiO2-TiO2 hybrid material suitable for animal cell encapsulation: towards the design of a transplantable artificial organ for use in new cell therapy … J OLIVET Université de Namur, Belgium, 2015		2015

The system can't perform the operation now. Try again later.

Articles 1–17

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors